EBS insider buying and SEC filings, explained
Emergent BioSolutions Inc. · CIK 1367644
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$996K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 7, 2026 | Planned (10b5-1) | Donald W DeGolyer (Director) sold 17,800 shares at about $7.09 ($126K), marked as a 10b5-1 plan trade. Holdings down 14% to 111,921 shares. | SEC filing Filed Oct 7, 2026, 3:45 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Paul Anthony Williams (SVP, Products Business) sold 3,000 shares at about $6.53 ($20K), marked as a 10b5-1 plan trade. Holdings down 2% to 156,098 shares. | SEC filing Filed Oct 5, 2026, 9:16 AM ET |
| Jul 1, 2026 | Planned (10b5-1) | Paul Anthony Williams (SVP, Products Business) sold 3,000 shares at about $8.40 ($25K), marked as a 10b5-1 plan trade. Holdings down 2% to 159,098 shares. | SEC filing Filed Jul 2, 2026 |
| May 1, 2026 | Planned (10b5-1) | Kathryn C Zoon (Director) sold 17,202 shares at about $8.40 ($144K), marked as a 10b5-1 plan trade. Holdings down 18% to 79,941 shares. | SEC filing Filed May 4, 2026 |
| May 1, 2026 | Planned (10b5-1) | Donald W DeGolyer (Director) sold 15,481 shares at about $8.40 ($130K), marked as a 10b5-1 plan trade. Holdings down 11% to 129,721 shares. | SEC filing Filed May 4, 2026 |
| May 1, 2026 | Planned (10b5-1) | Sujata Tyagi Dayal (Director) sold 13,761 shares at about $8.40 ($116K), marked as a 10b5-1 plan trade. Holdings down 12% to 100,563 shares. | SEC filing Filed May 4, 2026 |
| Apr 30, 2026 | Planned (10b5-1) | Keith Katkin (Director) sold 15,481 shares at about $8.28 ($128K), marked as a 10b5-1 plan trade. Holdings down 14% to 96,294 shares. | SEC filing Filed May 4, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Paul Anthony Williams (SVP, Products Business) sold 4,000 shares at about $8.44 ($34K), marked as a 10b5-1 plan trade. Holdings down 6% to 62,681 shares. | SEC filing Filed Apr 3, 2026 |
| Nov 10, 2025 | Planned (10b5-1) | Donald W DeGolyer (Director) sold 17,801 shares at about $10.54 ($188K), marked as a 10b5-1 plan trade. Holdings down 13% to 119,858 shares. | SEC filing Filed Nov 12, 2025 |
| Nov 7, 2025 | Planned (10b5-1) | Sujata Tyagi Dayal (Director) sold 8,552 shares at $10.00 ($86K), marked as a 10b5-1 plan trade. Holdings down 9% to 88,980 shares. | SEC filing Filed Nov 10, 2025 |
41 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 2, 2026, 4:06 PM ET 8-K | Earnings released (Item 2.02) Reg FD disclosure (Item 7.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow EBS in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.